Interview with Professor Juan Miguel Bayo Fina from the Faculty of Biomedical Sciences of the Universidad Austral A research fellow at CONICET and the Institute of Translational Medicine Research, speaking on Radio Independencia LV 12 in the province of Tucumán, discussed a new experimental therapeutic strategy that could benefit patients with severe liver disease. In a significant advance for Argentine translational science, researchers from the Laboratory of Experimental Hepatology and Gene Therapy (IIMT) identified for the first time an effective therapeutic pathway to treat fulminant hepatitis, a condition that can cause death in up to 40% of cases without transplantation.